Dual stimulation of MyD88-dependent toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells

Journal of Infectious Diseases

Volumn 202, Issue 2, 2010, Pages 318-329

  Mitchell, Daniel ^a   Yong, Michelle ^a   Schroder, Wayne ^a   Black, Matthew ^b   Tirrell, Matthew ^b   Olive, Colleen ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; CYTOKINE; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; MYD88 PROTEIN, MOUSE; RECOMBINANT PROTEIN; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOMETRY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CYTOKINES; DENDRITIC CELLS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MYELOID DIFFERENTIATION FACTOR 88; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS;

EID: 77954595083     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653499     Document Type: Article

References (50)

1. Hans D, Young PR, Fairlie DP. Current status of short synthetic peptides as vaccines. Med Chem 2006; 2:627-646
2. Nava-Parada P, Forni G, Knutson KL, Pease LR, Celis E. Peptide vaccination given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors. Cancer Res 2007; 67:1326-1334
3. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 2004; 199:227-250
4. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311:17-58.
5. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005; 17:338-344
6. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7:179-190
7. Hemmi H, Akira S. TLR signaling and the function of dendritic cells. Chem Immunol Allergy 2005; 86:120-135
8. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-376
9. Uematsu S, Akira S. Toll-like receptors and type I interferons. J Biol Chem 2007; 282:15319-15323
10. Yamamoto M, Sato S, Hemmi H, et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002; 420:324-329
11. Hazeki K, Nigorikawa K, Hazeki O. Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull 2007; 30:1617-1623
12. Fukao T, Tanabe M, Terauchi Y, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 2002; 3:875-881
13. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252
14. Wille-Reece U, Flynn BJ, Lore K, et al. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med 2006; 203:1249-1258
15. Agrawal S, Agrawal A, Doughty B, et al. Cutting edge: different Tolllike receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-fos. J Immunol 2003; 171:4984-4989
16. Vermorken JB, Claessen AM, van Tinteren H, et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 1999; 353:345-350
17. Baldridge JR, McGowan P, Evans JT, et al. Taking a Toll on human disease: Toll-like receptor agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 2004; 7:1129-1138
18. Link BK, Ballas ZK, Weisdorf D, et al. Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma. J Immunother 2006; 29:558-568
19. Napolitani G, Rinaldi A, Bertoni F, Sallustro F, Lanzavecchia, A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005; 6:769-776
20. Roelofs MF, Joosten LAB, Abdollahi-Roodsaz S. The expression of Tolllike receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005; 52:2313-2322
21. Warger T, Osterloh P, Rechtsteiner G, et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses. Blood 2006; 108:544-550
22. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 2005; 174:6592-6597
23. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007; 179: 7577-7584
24. Gilliet M, Boonstra A, Paturel C, et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 2002; 195:953-958
25. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000; 96:3029-3039
26. Naik SH, Sathe P, Park H-Y, et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007; 8:1217-1226
27. Brawand P, Fitzpatrick DR, Greenfield BW, Brasel K, Maliszewski CR, De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol 2002; 169:6711-6719
28. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60:1539-1545
29. Vanhoutte F, Paget C, Breuilh L, et al. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunol Lett 2008; 116:86-94.
30. Mäkelä SM, Strengell M, Pietilä TE, Osterland P, Julkunen I. Multiple signalling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leuk Biol 2009; 85:664-672
31. Bagchi A, Herrup EA, Warren HS, et al. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007; 178:1164-1171
32. Zhu Q, Egelston C, Vivekanandham A, et al. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci USA 2008; 105:16260-16265
33. De Smedt T, Pajak B, Muraille E, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996; 184:1413-1424
34. Dowling D, Hamilton CM, O'Neill SM. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands. Cytokine 2008; 41:254-262
35. Hirata N, Yanagawa Y, Ebihara T, et al. Selective synergy in anti-inflammatory cytokine production upon cooperated signalling via TLR4 and TLR2 in murine conventional dendritic cells. Mol Immunol 2008; 45:2734-2742
36. Dearman RJ, Cumberbatch M, Maxwell G, Basketter DA, Kimber I. Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology 2008; 126:475-484
37. Hemmi H, Kaisho K, Takeda K, Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003; 170:3059-3064
38. Hoshino K, Sugiyama T, Matsumoto M, et al. IkB kinase-α is critical for interferon-a production induced by Toll-like receptors 7 and 9. Nature 2006; 440:949-953
39. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine- paracrine loop is involved in Toll-like receptor-induced interleukin- 12p70 secretion by dendritic cells. J Exp Med 2005; 201:1435-1446
40. Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type I responses. Cell Immunol 2007; 247:72-84.
41. van Duin D, Medzhitov R, Shaw AC. Triggering TLR signalling in vaccination. Trends Immunol 2006; 27:49-55.
42. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signalrelated kinase mitogen-activated protein kinase and c-fos in dendritic cells. J Immunol 2004; 172:4733-4743
43. Redecke V, Häcker H, Datta SK, et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172:2739-2743
44. Didierlaurent A, Ferrero I, Otten LA, et al. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 2004; 172:6922-6930
45. Yanagawa Y, Onoé K. Enhanced IL-10 production by TLR4- and TLR2- primed dendritic cells upon TLR restimulation. J Immunol 2007; 178: 6173-6180
46. Jarnicki AG, Conroy H, Brereton C, et al. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J Immunol 2008; 180:3797-3806
47. Qian C, Jiang X, An H, et al. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 2006; 108:2307-2315
48. Kikuchi Y, Yanagawa Y, Iwabuchi K, Onoé K. Differential role of mitogen- activated protein kinases in CD40-mediated Il-12 production by immature and mature dendritic cells. Immunol Lett 2003; 89:149-154
49. Wymann MP, Pirola L. Structure and function of phosphoinositide 3- kinases. Biochim Biophys Acta 1998; 1436:127-150
50. Utsugi M, Dobashi K, Ono A, et al. PI3K p110b positively regulates lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role. J Immunol 2009; 182: 5225-5231